# Uscb Financial Holdings, Inc.: overview USCB · Nasdaq · CIK 1901637 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/uscb.md) · [Financials](/companies/uscb/financials.md) · [Filings](/companies/uscb/filings.md) · [Insiders](/companies/uscb/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.35](/filings/0001562762-25-000269.md) | not reported | [0.38](/filings/0001562762-26-000062.md) | [0.40](/filings/0001562762-26-000090.md) | [0.45](/filings/0001562762-25-000269.md) | not reported | [0.51](/filings/0001562762-26-000062.md) | [0.49](/filings/0001562762-26-000090.md) | | Free cash flow | $m | [11.2 d](/filings/0001562762-25-000269.md) | [(3.0) d](/filings/0001562762-26-000027.md) | [14.6](/filings/0001562762-26-000062.md) | [18.0 d](/filings/0001562762-26-000090.md) | [20.0 d](/filings/0001562762-25-000269.md) | [(10.1) d](/filings/0001562762-26-000027.md) | [15.0](/filings/0001562762-26-000062.md) | [24.2 d](/filings/0001562762-26-000090.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | not reported | not reported | not reported | [1.24](/filings/0001562762-26-000027.md) | [1.33](/filings/0001562762-26-000027.md) | | Free cash flow | $m | [21.4](/filings/0001562762-23-000140.md) | [28.9](/filings/0001562762-24-000061.md) | [22.4](/filings/0001562762-25-000043.md) | [34.5](/filings/0001562762-26-000027.md) | [42.5](/filings/0001562762-26-000027.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/uscb/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Patriot Financial Partners GP II, L.P.](/funds/2061817.md) | 2026-06-30 | $37.0m | 1,806,286 | | Reduced −50,000 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $21.9m | 1,071,823 | | Added +162,986 | | [ENDEAVOUR CAPITAL ADVISORS INC](/funds/1218749.md) | 2026-06-30 | $21.5m | 1,052,333 | | Added +27,595 | | [ALLIANCEBERNSTEIN L.P.](/funds/1109448.md) | 2026-06-30 | $18.1m | 974,023 | | Added +36,666 | | [MENDON CAPITAL ADVISORS CORP](/funds/1177043.md) | 2026-06-30 | $12.2m | 597,788 | | Added +23,688 | | [Curi Capital, LLC](/funds/1332905.md) | 2026-06-30 | $11.3m | 550,085 | | Added +22,981 | | [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $11.0m | 539,779 | | Added +81,450 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $10.0m | 489,668 | | Added +1,789 | | [BASSWOOD CAPITAL MANAGEMENT, L.L.C.](/funds/1085393.md) | 2026-06-30 | $8.9m | 436,892 | | Unchanged | | [Pacific Ridge Capital Partners, LLC](/funds/1591546.md) | 2026-06-30 | $7.0m | 339,688 | | Reduced −2,632 | ## Recent filings [All 299 filings](/companies/uscb/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-22 | 16:00 ET | [8-K](/filings/0001562762-26-000122.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001562762-26-000122 | | 2026-10-19 | 16:55 ET | [8-K](/filings/0000927089-26-000176.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000927089-26-000176 | | 2026-08-07 | 11:10 ET | [10-Q](/filings/0001562762-26-000090.md) | Quarterly report, period 2026-06-30 | 0001562762-26-000090 | | 2026-07-28 | 13:46 ET | [8-K](/filings/0001562762-26-000084.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001562762-26-000084 | | 2026-07-23 | 16:00 ET | [8-K](/filings/0001562762-26-000082.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001562762-26-000082 | | 2026-07-20 | 16:34 ET | [8-K](/filings/0000927089-26-000129.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000927089-26-000129 | | 2026-07-16 | 09:41 ET | [SCHEDULE 13D/A](/filings/0000927089-26-000122.md) | Ownership report, active investor, amended | 0000927089-26-000122 | | 2026-06-01 | 16:50 ET | [8-K](/filings/0000927089-26-000105.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000927089-26-000105 | | 2026-05-27 | 16:37 ET | [8-K](/filings/0000927089-26-000099.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0000927089-26-000099 | | 2026-05-08 | 12:57 ET | [10-Q](/filings/0001562762-26-000062.md) | Quarterly report, period 2026-03-31 | 0001562762-26-000062 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001562762-26-000027.md), filed Mar 13, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1901637 - Tickers: USCB - Exchange: Nasdaq - SIC code: 6022 State Commercial Banks - State of incorporation: FL - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 11:18 ET. No prices; not investment advice.